Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: Effectiveness goes on

AIDS

Volumn 20, Issue 2, 2006, Pages 289-291

  Pérez Hoyos, Santiago ^a,b   Ferreros, Inma ^a,c   Del Amo, Julia ^c   Muga, Roberto ^d   Del Romero, Jorge ^e   Garcia De Olalla, Patricia ^f   Hernández Aguado, Ildefonso ^c  

^a Generalitat Valenciana   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Sandoval Health Centre   (Spain)

^f AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HAZARD ASSESSMENT; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEROCONVERSION; SURVIVAL RATE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 33646055809     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000202651.41397.db     Document Type: Article

References (7)

1. Cascade Collaboration. Survival after introduction of HAART in people with known duration of HIV infection. AIDS 2000; 355:1158-1159.
2. Detels R, Muñoz A, McFarlane G, Kingsley L, Margolick JB, Giorgi JV, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 1998; 280:1497-1503.
3. Detels R, Tarwater P, Phair JP, Margolick JB, Riddler S, Muñoz A. Effectiveness of potent antiretroviral therapies on the incidence of oportunistic infections before and after AIDS diagnosis. AIDS 2001; 15:347-355.
4. Perez-Hoyos S, del Amo J, Muga R, del Romero J, Garcia DO, Guerrero R, Hernandez-Aguado I. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. AIDS 2003; 17:353-359.
5. Amundsen EJ, Fekjaer H. Progression to AIDS slowed even more after the first two years with highly active antiretroviral therapy. Scand J Public Health 2005; 31:312-318.
6. Cascade Collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003; 362:1267-1274.
7. GEMES. Period of incubation of AIDS in Spain after highly active antiretroviral therapy [in Spanish] Med Clin 2000; 115:681-686.